Guangdong Kanghua Healthcare Co., Ltd. Class H (HK:3689)
:3689
Top Page
Guangdong Kanghua Healthcare Co., Ltd. Class H
(3689)
Select Model
Select Model
Rating:71Outperform
Price Target:
HK$2.00
▲(16.28% Upside)
Action:UpgradedDate:10/16/25
The overall stock score of 71 reflects a strong valuation with a low P/E ratio and high dividend yield, making it attractive for value and income investors. However, technical indicators suggest some caution due to bearish momentum. Financial performance is mixed, with strong cash flow but declining profitability margins, which could impact long-term growth.
Positive Factors
Free cash flow strength
163.43% free cash flow growth indicates robust cash conversion from operations, improving liquidity and funding capacity for capex, dividends, or debt reduction. Durable cash generation strengthens financial flexibility and supports strategic investments over the medium term.
Negative Factors
Falling profit margins
Gross and net margin erosion points to rising costs or pricing pressure; net margin collapsing to 0.75% materially weakens retained earnings. Persistent margin decline undermines reinvestment capacity, reduces buffer for shocks, and hampers sustainable profitability.
Read all positive and negative factors
Positive Factors
Negative Factors
Free cash flow strength
163.43% free cash flow growth indicates robust cash conversion from operations, improving liquidity and funding capacity for capex, dividends, or debt reduction. Durable cash generation strengthens financial flexibility and supports strategic investments over the medium term.
Read all positive factors
Guangdong Kanghua Healthcare Co., Ltd. Class H (3689) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$678.82M
Dividend Yield9.14%
Average Volume (3M)1.02K
Price to Earnings (P/E)3.3
Beta (1Y)0.04
Revenue Growth0.47%
EPS Growth50.46%
CountryHK
Employees4,320
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)0.19
Shares Outstanding84,394,000
10 Day Avg. Volume720
30 Day Avg. Volume1,020
Financial Highlights & Ratios
PEG Ratio-0.57
Price to Book (P/B)0.53
Price to Sales (P/S)0.37
P/FCF Ratio3.97
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Guangdong Kanghua Healthcare Co., Ltd. Class H Business Overview & Revenue Model
Company Description
Guangdong Kanghua Healthcare Co., Ltd., an investment holding company, primarily operates private hospitals in the People's Republic of China. The company operates through Hospital Services, Rehabilitation and Other Healthcare Services, Sale of Ph...
How the Company Makes Money
Guangdong Kanghua Healthcare generates revenue through multiple streams, including the sale of pharmaceuticals, medical devices, and health management services. The company's pharmaceutical division focuses on developing and marketing prescription...
Guangdong Kanghua Healthcare Co., Ltd. Class H Financial Statement Overview
Summary
Income Statement
65
Positive
Balance Sheet
72
Positive
Cash Flow
78
Positive
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.05B | 2.06B | 2.04B | 1.85B | 1.95B | 1.75B |
| Gross Profit | 334.01M | 321.87M | 364.37M | 261.35M | 352.75M | 263.15M |
| EBITDA | 256.12M | 224.86M | 305.92M | 233.79M | 298.46M | 138.79M |
| Net Income | 76.52M | 15.34M | 121.06M | 59.70M | 94.31M | -25.37M |
Balance Sheet | ||||||
| Total Assets | 2.78B | 2.74B | 2.62B | 2.72B | 2.70B | 2.45B |
| Cash, Cash Equivalents and Short-Term Investments | 791.85M | 678.40M | 718.52M | 754.34M | 770.34M | 584.67M |
| Total Debt | 445.48M | 320.66M | 426.58M | 429.92M | 494.54M | 465.82M |
| Total Liabilities | 1.32B | 1.28B | 1.13B | 1.22B | 1.23B | 1.05B |
| Stockholders Equity | 1.45B | 1.44B | 1.42B | 1.49B | 1.43B | 1.33B |
Cash Flow | ||||||
| Free Cash Flow | 340.37M | 193.15M | 73.31M | 106.20M | 162.19M | 27.75M |
| Operating Cash Flow | 378.11M | 280.13M | 204.19M | 221.40M | 333.37M | 275.29M |
| Investing Cash Flow | -48.17M | -87.33M | -107.72M | -83.16M | -299.33M | -182.15M |
| Financing Cash Flow | -76.14M | -251.71M | -55.56M | -110.88M | 23.27M | -138.22M |
Guangdong Kanghua Healthcare Co., Ltd. Class H Technical Analysis
Positive
1.72
Price Trends
1.86
Positive
1.86
Positive
1.90
Positive
Market Momentum
0.05
Positive
56.83
Neutral
8.97
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:3689, the sentiment is Positive. The current price of 1.72 is below the 20-day moving average (MA) of 2.02, below the 50-day MA of 1.86, and below the 200-day MA of 1.90, indicating a bullish trend. The MACD of 0.05 indicates Positive momentum. The RSI at 56.83 is Neutral, neither overbought nor oversold. The STOCH value of 8.97 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:3689.
Guangdong Kanghua Healthcare Co., Ltd. Class H Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$356.42M | 4.98 | 4.28% | 7.10% | -2.88% | -22.83% | |
71 Outperform | HK$678.82M | 3.30 | 5.29% | 9.14% | 0.47% | 50.46% | |
56 Neutral | HK$545.87M | 5.00 | 31.63% | ― | 2.30% | ― | |
54 Neutral | HK$263.57M | -2.55 | -25.22% | 3.16% | -21.31% | -149.92% | |
52 Neutral | HK$311.23M | 4.11 | 3.54% | 3.75% | 9.07% | 8.95% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | HK$936.00M | -275.87 | 1.85% | ― | -13.22% | -69.35% |
* Healthcare Sector Average
HK:3689
Guangdong Kanghua Healthcare Co., Ltd. Class H
2.03
0.21
11.54%
HK:9906
Honliv Healthcare Management Group Co Ltd
1.56
0.02
1.30%
HK:1419
Human Health Holdings Ltd.
0.82
0.10
13.89%
HK:1518
New Century Healthcare Holding Co. Ltd.
0.54
-0.59
-52.21%
HK:3869
Hospital Corporation of China Ltd
3.95
-2.85
-41.91%
HK:0722
UMP Healthcare Holdings Limited
0.45
0.08
20.92%
Guangdong Kanghua Healthcare Co., Ltd. Class H Corporate Events
Guangdong Kanghua Healthcare Calls March EGM to Approve 2026 Hospital and Elderly Care Leases
Feb 3, 2026
Guangdong Kanghua Healthcare Group Co., Ltd. has convened an extraordinary general meeting for 3 March 2026 in Dongguan to seek shareholder approval for a series of 2026 lease agreements covering Kanghua Hospital, Renkang Hospital and the Renkang ...
Guangdong Kanghua Healthcare Further Delays Circular on 2026 Lease Deals
Jan 30, 2026
Guangdong Kanghua Healthcare Group has announced a further delay in sending a shareholder circular related to its 2026 lease agreements, which are categorized as major and connected transactions under Hong Kong listing rules. The circular, origina...
Guangdong Kanghua Healthcare Delays Circular on 2026 Lease Transactions
Jan 14, 2026
Guangdong Kanghua Healthcare Group Co., Ltd. has announced a delay in the dispatch of a shareholder circular related to its 2026 lease agreements, which constitute major and connected transactions under Hong Kong listing rules. The circular, origi...
Guangdong Kanghua Healthcare Secures New Leases for Key Hospitals in Major Connected Deal
Dec 22, 2025
Guangdong Kanghua Healthcare Group has entered into new 2026 lease agreements to secure continued use of the properties housing Kanghua Hospital and Renkang Hospital for three years from 1 January 2026 to 31 December 2028, following the expiry of ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.